Department of Environmental Health, School of Public Health, China Medical University, North 2nd Road 92, Heping ward, Shenyang, Liaoning, 110001, People's Republic of China,
Mol Neurobiol. 2015 Feb;51(1):68-88. doi: 10.1007/s12035-014-8789-3. Epub 2014 Jun 28.
Excessive manganese (Mn) induces oxidative stress and dopaminergic neurodegeneration. However, the relationship between them during Mn neurotoxicity has not been clarified. The purpose of this study was to investigate the probable role of melatonin (MLT) against Mn-induced motor dysfunction and neuronal loss as a result of antagonizing oxidative stress and dopaminergic neurodegeneration. Mice were randomly divided into five groups as follows: control, MnCl2, low MLT + MnCl2, median MLT + MnCl2, and high MLT + MnCl2. Administration of MnCl2 (50 mg/kg) for 2 weeks significantly induced hypokinesis, dopaminergic neurons degeneration and loss, neuronal ultrastructural damage, and apoptosis in the substantia nigra and the striatum. These conditions were caused in part by the overproduction of reactive oxygen species, malondialdehyde accumulation, and dysfunction of the nonenzymatic (GSH) and enzymatic (GSH-Px, superoxide dismutase, quinone oxidoreductase 1, glutathione S-transferase, and glutathione reductase) antioxidative defense systems. Mn-induced neuron degeneration, astrocytes, and microglia activation contribute to the changes of oxidative stress markers. Dopamine (DA) depletion and downregulation of DA transporter and receptors were also found after Mn administration, this might also trigger motor dysfunction and neurons loss. Pretreatment with MLT prevented Mn-induced oxidative stress and dopaminergic neurodegeneration and inhibited the interaction between them. As a result, pretreatment with MLT significantly alleviated Mn-induced motor dysfunction and neuronal loss. In conclusion, Mn treatment resulted in motor dysfunction and neuronal loss, possibly involving an interaction between oxidative stress and dopaminergic neurodegeneration in the substantia nigra and the striatum. Pretreatment with MLT attenuated Mn-induced neurotoxicity by means of its antioxidant properties and promotion of the DA system.
过量的锰 (Mn) 会引起氧化应激和多巴胺能神经元变性。然而,它们在 Mn 神经毒性中的关系尚未阐明。本研究旨在探讨褪黑素 (MLT) 作为一种抗氧化应激和多巴胺能神经元变性的拮抗剂,可能在对抗 Mn 诱导的运动功能障碍和神经元丢失方面发挥作用。
对照组、MnCl2 组、低剂量 MLT+MnCl2 组、中剂量 MLT+MnCl2 组和高剂量 MLT+MnCl2 组。给予 MnCl2(50mg/kg)连续 2 周后,明显导致运动功能减退、多巴胺能神经元变性和丢失、神经元超微结构损伤和黑质及纹状体的细胞凋亡。这些变化部分是由于活性氧(ROS)过度产生、丙二醛(MDA)积累以及非酶(GSH)和酶(GSH-Px、超氧化物歧化酶、醌氧化还原酶 1、谷胱甘肽 S-转移酶和谷胱甘肽还原酶)抗氧化防御系统功能障碍所致。Mn 诱导的神经元变性、星形胶质细胞和小胶质细胞激活导致氧化应激标志物的变化。给予 Mn 后还发现多巴胺(DA)耗竭和 DA 转运体和受体下调,这可能也会引发运动功能障碍和神经元丢失。给予 MLT 预处理可预防 Mn 诱导的氧化应激和多巴胺能神经元变性,并抑制它们之间的相互作用。因此,MLT 预处理可显著缓解 Mn 诱导的运动功能障碍和神经元丢失。
综上所述,Mn 处理可导致运动功能障碍和神经元丢失,这可能涉及黑质和纹状体中氧化应激和多巴胺能神经元变性的相互作用。MLT 通过其抗氧化特性和促进 DA 系统,减轻 Mn 诱导的神经毒性。